CN Stock MarketDetailed Quotes

688331 RemeGen Co., Ltd.

Watchlist
  • 37.00
  • +5.68+18.14%
Market Closed Nov 1 15:00 CST
20.14BMarket Cap-12977P/E (TTM)

RemeGen Co., Ltd. Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

RemeGen Co., Ltd. FY2024 9-Month Earnings Date

Currency：CNYOct 29, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
--
1.21B
--
+57.10%
EPS
--
-1.99
--
-2.65%
Analyst Rating
Strong Buy

Nov 3, 2024

RemeGen Co., Ltd. Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 7 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
Date Period Revenue/Estimate Earnings Call
-- 2025/FY -- / 2.338B --
-- 2024/FY -- / 1.673B --
-- 2023/FY 1.083B / 1.129B --
Mar 30, 2023 2022/FY 772.109M / 870.124M --
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 2.338B--
--2024/FY-- / 1.673B--
--2023/FY1.083B / 1.129B--
Mar 30, 20232022/FY772.109M / 870.124M--
--------

Unlock Free Earnings Estimates

RemeGen Co., Ltd. Earnings Reports

  • Rongchang Biopharmaceutical (Yantai) Co., Ltd. 2024 Third Quarter Report

    Oct 30 00:00

  • Remegen Biopharmaceutical (Yantai) Co., Ltd. 2024 Semi-annual Report

    Aug 17 00:00

  • Summary of Remegen (Yantai) Co., Ltd.'s 2024 Interim Report

    Aug 17 00:00

  • Rongchang Biopharmaceutical (Yantai) Co., Ltd. 2024 First Quarter Report

    Apr 27 00:00

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 3, 2024

    Strong Buy

    • Strong Buy

      81.25%

    • Buy

      12.50%

    • Hold

      6.25%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    % Chg

    No Data